Learn More
Medchemexpress LLC Amiselimod hydrochloride | 942398-84-7 | 98.7% | 413.90 | 100 MG

Supplier: Medchemexpress LLC HY16734A100MG
Amiselimod hydrochloride is converted to its active metabolite Amiselimod phosphate by sphingosine kinases in vivo. It is an orally active and highly selective sphingosine 1-phosphate receptor-1 (S1P1) agonist. This compound is designed to reduce the bradycardia effects associated with fingolimod and other S1P receptor modulators. Amiselimod hydrochloride inhibits chronic colitis by preventing the infiltration of colitogenic Th1 and Th17 cells into the colon and inhibits lupus nephritis by reducing the infiltration of autoreactive T cells into the kidneys. It shows promise for the research of autoimmune diseases.
- Orally active and highly selective sphingosine 1-phosphate receptor-1 (S1P1) agonist.
- Designed to reduce bradycardia effects compared to other S1P receptor modulators.
- Inhibits chronic colitis.
- Inhibits lupus nephritis.
- Promising for research of autoimmune diseases.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.